Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hepatitis C
MedTech
FDA unlocks faster clearances for future hepatitis C diagnostics
The reclassification allows diagnostic developers to seek 510(k) clearances instead of completing full premarket approval applications.
Conor Hale
Nov 22, 2021 11:21am
Gilead's virology lead Brainard jumps ship to AlloVir
Mar 23, 2021 7:25am
Ascletis poaches top MSD China exec as its new R&D chief
Mar 1, 2019 9:53am
Ascletis files for Hong Kong IPO
May 8, 2018 9:19am
Bleeding cash, Achillion to cut 20% of workforce
Feb 22, 2018 11:05am
New research on T cells could boost search for HIV vaccine
Jan 19, 2018 2:57pm